211 
 |
An interesting article re JP Morgan life sciences conference
http://www.fiercebiotech.com/story/biote ch-execs-leave-jp-morgan-mixed-feelings- about-year-ahead-page-2/2012-01-12
|
 |
Happy new year
Happy new year to all and good luck re investment choices in the biomedical company year to come!
|
|
|
I am now at the Australian annual biotech/medical investment conference
I am down at the Australian BioShares annual biotech/medical investment conference. A good event this year with speakers including analysts and such comapnies as UBI, CGS, SHC, BTA, POH, ACL, QRX & PYC. The conference moved to Queenstown, New Zealand this year - a much better venue!
|
|
|
mid-month poll voting update
The strongest BUY/HOLD from poll votes by the community over the last month has been Universal Biosensors (UBI) which has risen 30% during the month –good stock picking by the community!
The strongest SELL vote by the community in the last month has been Phramaxis (PXS) which has dropped 20% during that period. Also a good prediction by the community votes. See the Poss… |
|
|
Monthly data update from community votes
Some updates on the data the community has created in recent weeks via POLL voting.
“Investor sentiment” has moved more to a sell situation with the “(Buy+Hold) to Sell” ratio now 1.7, in favour of Sell votes. Top 4 stocks voted by the community as BUY are: Viralytics, Sunshine Heart, Pharmaxis & Universal Biosensors Top 4 stocks voted by the comm… |
 |
Mesoblast
I'm just wondering why no one has mentioned, blogged or Top 10'ed the company "Mesoblast" (MSB). It's the steepest curve I've ever seen. I got in at 6.90 and exited at 8.00 and made a healthy profit. However, as I'm a total beginner, I didn't have a strategy. I saw it... it was the best looking graph on the ASX website, I wanted to have a punt and so I was in it for 1 week (Monday to Mon…
|
 |
iSOFT in trading halt?
iSOFT in trading halt? I am a holder of the stock...
|
|
|
Chemgenex - beaten down and will it move
Chemgenex was beaten down after the first FDA feedback but has now started to move a little. Given the more recent FDA feedback they had from a 2nd meeting will this stock re-visit the $1 range it was in? I am not currently a shareholder.
|
|
|
Australian Biomedical shares conference - BioShares Thredbo
I attended the annual BioShares conference in Thredbo about 1 week ago. A great event with a solid gathering of leading Australian Biotech & Medical device CEOs and Venture Capitalists. Next year's event will be in Queenstown NZ – a change of venue given it has been in Thredbo for the last 6 years or so. I recommend the event.
|
|
|
Viralytics - well positioned with a Phase II about to begin
Is Viralytics well positioned with a Phase II about to begin considering its rival coampnies with similar approaches yet different viruses have market caps between $150M to 200M with Phase II & Phase III candidates. Also does anyone have insight into Viralytics likely relase date of its current Phase I trials re head and neck & breast cance?
|
Terms & Rules
As per ASIC Regulatory Guide 162: All investment tips and comments appearing on this website (Poll results, BLOGS & discussion forums) are submitted by the general public who are not licensed financial advisors. None of the information on this website is financial or investment advice, you should seek independent financial or investment advice by a licensed financial or investment advisor before entering into any position of financial risk. Before using this website, you must agree to the BioInvesting.com.au Terms Of Use